Abstract
Purpose Human immunodeficiency virus (HIV) infection has detrimental impacts on the lives of different population groups living with HIV, including men who have sex with men (MSM). Using the World Health Organization Quality of Life Questionnaire (WHOQOL – HIV BREF), this study aimed to assess the Health-Related Quality of Life (HrQoL) of men living with HIV with different sexual orientations and determine the dominant influential factors.
Methods This cross-sectional study involved 206 men living with HIV. They were recruited from Sriwijaya Plus Foundation and a medical facility providing antiretroviral therapy (ART). Data were analyzed using Chi-square and binomial logistic regression.
Results The analysis showed that the percentage of MSM patients was more than non-MSM/heterosexual men, accounting for 68.9% of the total population. Furthermore, depression status, social stigma, family support, therapy duration, and suffering duration were significantly associated with the quality of life of MSM and non-MSM (p-value <0.001). The multivariate logistic regression revealed that the most dominant influential factor was depression status (PR=5.417; 95% CI=2.473-11.876), where the majority of the depressed patients were 5.417 times more at risk of lower life quality compared to others.
Conclusion Depression can lead to low quality of life among HIV patients. The findings suggest that there is a need for the development of intervention programs that address the psychological and social needs of PLHIV or support them to cope with depression and the social stigma facing them. Support from families and health workers can help them cope with psychological and social challenges faced by PLHIV and increase community acceptance of PLHIV.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the ethical review committee of the Faculty of Public Health Sriwijaya University with reference number 149/UN9.FKM/TU.KKE/2021.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
